Edward T Mathers
CIK 1328625 · EVP, Corporate Dev. & Venture · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$415.75M
Companies
19
Total Filings
83
Lifetime Open-Market Net
$47.23M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OKUR | Director | 15,310 | $4.20 | $64.3K | $0 | 7 | 2026-06-08 |
| MBX | Director | 1,023,103 | $35.51 | $36.33M | $8.00M | 4 | 2026-06-05 |
| TRVI | Director | 948,948 | $14.21 | $13.48M | $0 | 9 | 2026-06-04 |
| RYTM | Director | 21,168 | $88.38 | $1.87M | $0 | 14 | 2026-03-16 |
| KRRO | 10%+ Owner | 1,297,893 | $11.61 | $15.07M | $3.30M | 2 | 2026-03-12 |
| SGP | 10%+ Owner | 6,035,038 | $18.44 | $111.29M | $15.00M | 1 | 2026-02-11 |
| NeueHealth, Inc. (BHG) Delisted | Director | 488,982 | $16.35 | $7.99M | -$24.5K | 6 | 2025-10-06 |
| SNTI | Director | — | $0.96 | — | $0 | 5 | 2025-06-27 |
| NeueHealth, Inc. (NEUE) Delisted | 10%+ Owner | — | $6.75 | — | $0 | 2 | 2024-10-03 |
| Inozyme Pharma, Inc. (INZY) Delisted | Director | — | $4.00 | — | $0 | 5 | 2024-06-20 |
| SVRA | 10%+ Owner | 24,471,264 | $5.26 | $128.72M | $1000.0K | 1 | 2023-07-19 |
| SYBX | Director | — | $0.69 | — | $0 | 8 | 2023-06-26 |
| OnKure Therapeutics, Inc. (RPHM) Delisted | Director | — | $18.20 | — | $0 | 3 | 2023-06-08 |
| Akouos, Inc. (AKUS) Delisted | Director | — | $13.29 | — | $0 | 3 | 2022-12-02 |
| MIRM | Director | — | $99.34 | — | $0 | 3 | 2022-06-06 |
| GLUE | 10%+ Owner | 5,973,296 | $18.23 | $108.92M | $19.95M | 1 | 2021-06-30 |
| Ra Pharmaceuticals, Inc. (RARX) Delisted | Director | — | — | — | $0 | 4 | 2020-04-03 |
| SYNLOGIC, INC. (MIRN) Delisted | Director | — | — | — | $0 | 1 | 2016-09-06 |
| MEDI | EVP, Corporate Dev. & Venture | — | $31.04 | — | $0 | 2 | 2007-06-19 |
Recent Filings · Page 3 of 9
83 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-10-03 | NeueHealth, Inc. (NEUE) Delisted | Buy (P) | — | $0 | EDGAR |
| 2024-09-17 | MBX | Mixed | +3,614,486 | $8.00M | EDGAR |
| 2024-09-13 | MBX | Grant (A) | — | $0 | EDGAR |
| 2024-07-12 | SNTI | Grant (A) | — | $0 | EDGAR |
| 2024-06-25 | RYTM | Exer (M) | +3,000 | $0 | EDGAR |
| 2024-06-20 | Inozyme Pharma, Inc. (INZY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-20 | RYTM | Grant (A) | — | $0 | EDGAR |
| 2024-06-14 | TRVI | Grant (A) | — | $0 | EDGAR |
| 2024-04-24 | KRRO | Buy (P) | +17,857 | $1000.0K | EDGAR |
| 2024-04-10 | NeueHealth, Inc. (NEUE) Delisted | Buy (P) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.